Phase II Transparency Report
On May 19, 2010, the Transparency Task Force released a report containing 21 draft proposals about expanding the disclosure of information by FDA while maintaining confidentiality for trade secrets and individually identifiable patient information. FDA accepted public comment on the content of the proposals, as well as on which draft proposals should be given priority, on this website from May 19, 2010 through July 20, 2010.
Not all these proposals will necessarily be implemented. Some may require changes in law or regulation; some may require substantial amounts of resources.
The table of contents for the report is found in the box to the left, under "Phase II Transparency Report." To read a section of the report, click on the name of the section.
To read and view comments on a draft proposal:
- Click on "Draft Proposals by Topic Area" (in the box on the left of the screen)
- Click on the topic area you would like to comment on (directly under "Draft Proposals by Topic Area" on the left of the screen)
- Scroll down page to find the proposal you would like to comment on
- Click on "Read the reasoning for this proposal and view comments"
You can view the comments that have been submitted about the draft proposals by following the instructions above.